Home > Publications Database > Author Correction: Reverse engineering synthetic antiviral amyloids. > print

001     258681
005     20231004134648.0
024 7 _ |a 10.1038/s41467-023-39293-9
|2 doi
024 7 _ |a pmid:37311856
|2 pmid
024 7 _ |a pmc:PMC10264350
|2 pmc
024 7 _ |a altmetric:149964764
|2 altmetric
037 _ _ |a DZNE-2023-00654
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Michiels, Emiel
|0 0000-0001-6065-5576
|b 0
245 _ _ |a Author Correction: Reverse engineering synthetic antiviral amyloids.
260 _ _ |a [London]
|c 2023
|b Nature Publishing Group UK
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1688473926_1579
|2 PUB:(DE-HGF)
|x Erratum/Correction
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
700 1 _ |a Roose, Kenny
|0 0000-0002-5270-4603
|b 1
700 1 _ |a Gallardo, Rodrigo
|0 0000-0003-1584-3564
|b 2
700 1 _ |a Khodaparast, Ladan
|b 3
700 1 _ |a Khodaparast, Laleh
|b 4
700 1 _ |a van der Kant, Rob
|0 0000-0003-3639-9749
|b 5
700 1 _ |a Siemons, Maxime
|b 6
700 1 _ |a Houben, Bert
|0 0000-0002-6750-011X
|b 7
700 1 _ |a Ramakers, Meine
|b 8
700 1 _ |a Wilkinson, Hannah
|b 9
700 1 _ |a Guerreiro, Patricia
|b 10
700 1 _ |a Louros, Nikolaos
|b 11
700 1 _ |a Kaptein, Suzanne J F
|0 0000-0002-7935-0219
|b 12
700 1 _ |a Ibañez, Lorena Itatí
|0 0000-0002-9393-2004
|b 13
700 1 _ |a Smet, Anouk
|b 14
700 1 _ |a Baatsen, Pieter
|b 15
700 1 _ |a Liu, Shu
|0 P:(DE-2719)2810461
|b 16
|u dzne
700 1 _ |a Vorberg, Ina
|0 P:(DE-2719)2481765
|b 17
700 1 _ |a Bormans, Guy
|b 18
700 1 _ |a Neyts, Johan
|b 19
700 1 _ |a Saelens, Xavier
|0 0000-0002-3861-6965
|b 20
700 1 _ |a Rousseau, Frederic
|0 0000-0002-9189-7399
|b 21
700 1 _ |a Schymkowitz, Joost
|0 0000-0003-2020-0168
|b 22
773 _ _ |a 10.1038/s41467-023-39293-9
|g Vol. 14, no. 1, p. 3492
|0 PERI:(DE-600)2553671-0
|n 1
|p 3492
|t Nature Communications
|v 14
|y 2023
|x 2041-1723
787 0 _ |a Michiels, Emiel et.al.
|d [London] : Nature Publishing Group UK, 2020
|i RelatedTo
|0 DZNE-2020-01310
|r
|t Reverse engineering synthetic antiviral amyloids.
856 4 _ |u https://www.nature.com/articles/s41467-023-39293-9
856 4 _ |u https://pub.dzne.de/record/258681/files/DZNE-2023-00654.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/258681/files/DZNE-2023-00654.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:258681
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 16
|6 P:(DE-2719)2810461
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 17
|6 P:(DE-2719)2481765
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-11
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-11
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2022-11-11
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2022-11-11
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2022
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T09:09:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T09:09:09Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2023-05-02T09:09:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2023-08-29
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b NAT COMMUN : 2022
|d 2023-08-29
920 1 _ |0 I:(DE-2719)1013004
|k AG Vorberg
|l Prion Cell Biology
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1013004
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21